Compare Hims and Hers Health Inc (HIMS) vs Cloudflare Inc (NET) Price & Performance

Hims & Hers Health trades at $30.92, up 4.67% on the day, amid a bearish technical signal and significant legal headwinds from multiple securities class action lawsuits. The stock shows mixed fundamentals with strong revenue growth to $2.35 billion in 2025 but a sharp reversal to a net loss of -$142 million in 2026, reflecting profitability challenges. Valuation ratios appear elevated with a P/E of 57.14 and EV/EBITDA of 205.86, while analyst consensus remains cautiously optimistic with a $32.17 price target.

The outlook is clouded by legal risks and recent earnings misses, though the company's gross margin of 68.43% indicates underlying business strength. Investment opportunity hinges on resolving regulatory scrutiny and returning to profitability, but near-term volatility is likely. Key risks include the FTC lawsuit outcome and sustained negative cash flow, demanding careful risk assessment by investors.

Cloudflare (NET) trades at $361.00, up 5.3% in the last session, with strong technical momentum and bullish moving average signals. The company shows robust revenue growth, reaching $2.17B in 2025, but remains unprofitable with a net margin of -8.21%. Recent product launches like Cloudflare Basin and strategic partnerships with Deutsche Telekom highlight innovation, while analyst consensus is strongly bullish with 71% buy ratings and a $328.71 price target.

Outlook: Growth prospects are solid with accelerating revenue and enterprise adoption, but high valuation multiples (P/S 47.88) and persistent losses pose risks. Investors should weigh the company's market leadership against profitability challenges and competitive pressures in the edge cloud space.